Swarnlata Saraf

Swarnlata Saraf

Auto-generated profile, based on publicly available information

Swarnlata Saraf

Pt. Ravishankar Shukla University

Research Focus & Metrics

Academic Career Length

57Years (1970-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2006 in Biological and Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
MRManju Rawat
Manju Rawat
DSDeependra Singh
Deependra Singh
SSSwarnlata Saraf
Swarnlata Saraf
Development of new delivery systems that deliver the potential drug specifically to the target site in order to meet the therapeutic needs of the patients at the required time and level remains the key challenge in the field of pharmaceutical biotechnology. Developments in this context to achieve desired goal has led to the evolution of the multidisciplinary field nanobiotechnology which involves the combination of two most promising technologies of 21st century—biotechnology and nanotechnology. Nanobiotechnology encompasses a wide array of different techniques to improve the delivery of biotech drugs, and nanoparticles offer the most suitable form whose properties can be tailored by chemical methods. This review highlights the different types of nanoparticulate delivery systems employed for biotech drugs in the field of molecular medicine with a short overlook at its applications and the probable associated drawbacks.

23 May 2008 in Journal of Inclusion Phenomena and Macrocyclic Chemistry
Verified
Journal Article
Closed access
PDF file
AVAmber Vyas
Amber Vyas
SSShailendra Saraf
Shailendra Saraf
SSSwarnlata Saraf
Swarnlata Saraf

1 November 2014 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
AAAmit Alexander
Amit Alexander
AJAjazuddin
Ajazuddin
JKJunaid Khan
Junaid Khan
SSSwarnlata Saraf
Swarnlata Saraf
SSShailendra Saraf
Shailendra Saraf

1 January 2010 in Pharmacognosy Research
Verified
Journal Article
Open access
PDF file
SSSwarnlata Saraf
Swarnlata Saraf
DKDr. Chanchal Deep Kaur
Dr. Chanchal Deep Kaur
The aim of this study was to evaluate ultraviolet (UV) absorption ability of volatile and nonvolatile herbal oils used in sunscreens or cosmetics and express the same in terms of sun protection factor (SPF) values. Sun protection factor is a laboratory measure of the effectiveness of sunscreen; the higher the SPF, the more protection a sunscreen offers against the ultraviolet radiations causing sunburn. The in vitro SPF is determined according to the spectrophotometric method of Mansur et al. Hydroalcoholic dilutions of oils were prepared, and in vitro photoprotective activity was studied by UV spectrophotometric method in the range of 290-320 nm. It can be observed that the SPF values found for nonvolatile oils were in between 2 and 8; and for volatile oils, in between 1 and 7. Among the fixed oils taken, SPF value of olive oil was found to be the highest. Similarly among essential oils, SPF value of peppermint oil was found to be the highest. The study will be helpful in the selection of oils and fragrances to develop sunscreens with better safety and high SPF. Oily vehicles are more effective for producing a uniform and long-lasting film of sunscreen on the skin, and their emollient properties protect the skin against the drying effects of exposure to wind and sun. Volatile oils are used as perfumes in cosmetics.


4 January 2017 in Artificial Cells, Nanomedicine, and Biotechnology
Verified
Journal Article
Closed access
MJManmohan Singh Jangdey
Manmohan Singh Jangdey
AGAnshita Gupta
Anshita Gupta
SSShailendra Saraf
Shailendra Saraf
SSSwarnlata Saraf
Swarnlata Saraf
The aim of this work is to apply Box-Behnken design to optimize the transfersomes were formulated by modified rotary evaporation sonication technique using surfactant Tween 80. The response surface methodology was used having three-factored with three levels. The prepared formulations were characterized for vesicle shape, size, entrapment efficiency (%), stability, and in vitro permeation. The result showed that drug entrapment of 84.24% with average vesicle size of 35.41 nm and drug loading of 8.042%. Thus, optimized formulation was found good stability and is a promising approach to improve the permeability of apigenin in sustained release for prolonged period of time.